Literature DB >> 17388998

Insight and danger in Alzheimer's disease.

S E Starkstein1, R Jorge, R Mizrahi, J Adrian, R G Robinson.   

Abstract

To determine the frequency, and demographic and clinical correlates of dangerous behaviours in Alzheimer's disease (AD). We assessed a consecutive series of 278 patients with AD and 45 age-comparable healthy controls with a comprehensive psychiatric and neuropsychological evaluation. Caregivers rated the frequency of patients' exposure to dangerous situations or commission of dangerous behaviours. The frequency of dangerous behaviours was 16% in the AD group and 2% in the healthy control group. The presence of anosognosia was associated with a threefold increase in the risk of dangerous behaviours, but there was no significant association between dangerous behaviours and patients' age, years of education, diagnosis of major or minor depression and presence of suicide ideation. Sixteen per cent of a consecutive series of patients with AD had dangerous behaviours during the month preceding the clinical evaluation. Anosognosia was the main clinical correlate of dangerous behaviours in this population.

Entities:  

Mesh:

Year:  2007        PMID: 17388998     DOI: 10.1111/j.1468-1331.2007.01745.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  24 in total

1.  Alzheimer's disease can spare local metacognition despite global anosognosia: revisiting the confidence-accuracy relationship in episodic memory.

Authors:  David A Gallo; Stefanie J Cramer; Jessica T Wong; David A Bennett
Journal:  Neuropsychologia       Date:  2012-06-18       Impact factor: 3.139

2.  A diagnostic formulation for anosognosia in Alzheimer's disease.

Authors:  S E Starkstein; R Jorge; R Mizrahi; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

3.  Reduced Awareness of Memory Deficit is Associated With Increased Medicare Home Health Care Use in Dementia.

Authors:  Brittany DeFeis; Silvia Chapman; Carolyn Zhu; Martina Azar; Preeti Sunderaraman; Katherine Ornstein; Yian Gu; Stephanie Cosentino
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jan-Mar       Impact factor: 2.703

4.  Mood and Personality Characteristics are Associated with Metamemory Knowledge Accuracy in a Community-Based Cohort of Older Adults.

Authors:  Leigh E Colvin; Matteo Malgaroli; Silvia Chapman; Anna MacKay-Brandt; Stephanie Cosentino
Journal:  J Int Neuropsychol Soc       Date:  2018-02-05       Impact factor: 2.892

5.  Key psychosocial interventions for Alzheimer's disease: an update.

Authors:  Edmund Howe
Journal:  Psychiatry (Edgmont)       Date:  2008-02

6.  Neuropsychological Correlates of Anosognosia for Objective Functional Difficulties in Older Adults on the Mild Cognitive Impairment Spectrum.

Authors:  Kayla A Steward; Tyler P Bull; Richard Kennedy; Michael Crowe; Virginia G Wadley
Journal:  Arch Clin Neuropsychol       Date:  2020-05-22       Impact factor: 2.813

Review 7.  Integrating the Constructs of Anosognosia and Metacognition: a Review of Recent Findings in Dementia.

Authors:  Preeti Sunderaraman; Stephanie Cosentino
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

8.  Medial prefrontal functional connectivity--relation to memory self-appraisal accuracy in older adults with and without memory disorders.

Authors:  Michele L Ries; Donald G McLaren; Barbara B Bendlin; Howard A Rowley; Rasmus Birn; Erik K Kastman; Mark A Sager; Sanjay Asthana; Sterling C Johnson
Journal:  Neuropsychologia       Date:  2012-01-02       Impact factor: 3.139

9.  Poor awareness of IADL deficits is associated with reduced regional brain volume in older adults with cognitive impairment.

Authors:  Kayla A Steward; Richard Kennedy; Guray Erus; Ilya M Nasrallah; Virginia G Wadley
Journal:  Neuropsychologia       Date:  2019-05-04       Impact factor: 3.139

10.  Minimal hepatic encephalopathy matters in daily life.

Authors:  Jasmohan S Bajaj
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.